Maravai LifeSciences (NASDAQ:MRVI) Research Coverage Started at Wells Fargo & Company
Wells Fargo & Company began coverage on shares of Maravai LifeSciences (NASDAQ:MRVI – Free Report) in a research report sent to investors on Tuesday, Marketbeat reports. The firm issued an overweight rating and a $10.00 price target on the stock. A number of other analysts have also commented on the company. Morgan Stanley lowered Maravai […]
More Stories
Hasbro, Inc. (NASDAQ:HAS) Shares Purchased by FNY Investment Advisers LLC
FNY Investment Advisers LLC lifted its position in shares of Hasbro, Inc. (NASDAQ:HAS – Free Report) by 59.0% during the...
Pinnacle Wealth Management Group Inc. Has $565,000 Stock Position in Brookfield Infrastructure Co. (NASDAQ:BIPC)
Pinnacle Wealth Management Group Inc. decreased its holdings in shares of Brookfield Infrastructure Co. (NASDAQ:BIPC – Free Report) by 5.0%...
Friedenthal Financial Makes New Investment in Hilton Worldwide Holdings Inc. (NYSE:HLT)
Friedenthal Financial acquired a new stake in Hilton Worldwide Holdings Inc. (NYSE:HLT – Free Report) in the fourth quarter, according...
Unique Wealth LLC Buys 493 Shares of Automatic Data Processing, Inc. (NASDAQ:ADP)
Unique Wealth LLC increased its stake in shares of Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report) by 9.7% in...
CHB Investment Group LLC Sells 1,858 Shares of SPDR Global Dow ETF (NYSEARCA:DGT)
CHB Investment Group LLC reduced its holdings in shares of SPDR Global Dow ETF (NYSEARCA:DGT – Free Report) by 12.9%...
Unique Wealth LLC Acquires 73,988 Shares of Fidelity Blue Chip Growth ETF (BATS:FBCG)
Unique Wealth LLC grew its holdings in Fidelity Blue Chip Growth ETF (BATS:FBCG – Free Report) by 97.2% in the...